Ars Pharmaceuticals Inc (SPRY)

02:38 AM

When is ARS Pharmaceuticals Inc. stock expected to show significant growthProven strategies for superior portfolio growth - jammulinksnews.com

02:38 AM

02:06 AM

Is ARS Pharmaceuticals Inc. a growth stock or a value stockExceptional financial outcomes - jammulinksnews.com

02:06 AM

11:37 AM

What makes ARS Pharmaceuticals Inc. stock price move sharplyUnlock your trading potential with expert tips - jammulinksnews.com

11:37 AM

10:30 AM

Should I hold or sell ARS Pharmaceuticals Inc. stock in 2025Consistent double returns - jammulinksnews.com

10:30 AM

Jul 25, 2025

ARS Pharmaceuticals Inc. Stock Analysis and ForecastBreakthrough financial growth - PrintWeekIndia

Jul 25, 2025

Jul 24, 2025

Is ARS Pharmaceuticals Inc. a good long term investmentTriple-digit return opportunities - PrintWeekIndia

Jul 24, 2025

Jul 23, 2025

What drives ARS Pharmaceuticals Inc. stock priceTremendous growth opportunities - Autocar Professional

Jul 23, 2025

Jul 22, 2025

What analysts say about ARS Pharmaceuticals Inc. stockBreakthrough stock performance - jammulinksnews.com

Jul 22, 2025

Jul 18, 2025

MHRA approves needle-free adrenaline nasal spray for anaphylaxis - Yahoo Finance

Jul 18, 2025

Jul 18, 2025

EURneffy® (adrenaline nasal spray) Approved in the U.K. as - GlobeNewswire

Jul 18, 2025

Jul 18, 2025

EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis) - Yahoo Finance

Jul 18, 2025

Jul 15, 2025

ARS Pharmaceuticals, Inc. (SPRY) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Jul 15, 2025

Jul 15, 2025

Wall Street Analysts See a 78.77% Upside in ARS Pharmaceuticals, Inc. (SPRY): Can the Stock Really Move This High? - Yahoo Finance

Jul 15, 2025

Jul 15, 2025

What Makes ARS Pharmaceuticals, Inc. (SPRY) a Good Fit for 'Trend Investing' - Yahoo Finance

Jul 15, 2025

Jul 10, 2025

ARS Pharmaceuticals: High Risk High Reward Rollout Of No Needle Epinephrine (SPRY) - Seeking Alpha

Jul 10, 2025

Jul 09, 2025

(SPRY) Technical Data - news.stocktradersdaily.com

Jul 09, 2025

Jul 09, 2025

ARS Pharmaceuticals: 'Betting On The Come' (NASDAQ:SPRY) - Seeking Alpha

Jul 09, 2025

Jul 03, 2025

ARS Pharmaceuticals: Insider Liquidity vs. Institutional Buying – A Contrarian Opportunity? - AInvest

Jul 03, 2025

Jul 01, 2025

ARS Pharmaceuticals: Navigating Insider Sales Amid Growth Catalysts - AInvest

Jul 01, 2025

Jun 30, 2025

Raymond James reiterates strong buy on ARS Pharmaceuticals stock - Investing.com

Jun 30, 2025

Jun 27, 2025

ARS Pharmaceuticals (SPRY) Soars 4.48% on Earnings, Partnership - AInvest

Jun 27, 2025

Jun 26, 2025

ARS Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 26, 2025

Jun 23, 2025

High Growth Tech Stocks in US for June 2025 - simplywall.st

Jun 23, 2025

Jun 21, 2025

Ars pharma CCO Karas sells $240k in SPRY stock - Investing.com India

Jun 21, 2025

Jun 18, 2025

Learn to Evaluate (SPRY) using the Charts - news.stocktradersdaily.com

Jun 18, 2025

Jun 18, 2025

ARS Pharmaceuticals | 6/18/25 - ktnv.com

Jun 18, 2025

Jun 18, 2025

FDA Reviewing Oral Epinephrine Film for Possible Approval - Allergic Living

Jun 18, 2025

Jun 17, 2025

Asthma Market to Expand Significantly by 2034, States - openPR.com

Jun 17, 2025